NEA and Revolution Growth leads Series C round for Tempus

Chicago-based Tempus, which is building a library of molecular and clinical data, has raised $70 million in Series C funding. New Enterprise Associates and Revolution Growth led the round.

26 September 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail